MedPath

Blended Vegetable and Fruit Juice Containing Lactobacillus paracasei Lowers Blood Lipid Levels and Oxidative Stress Markers in Thai Dyslipidemia Subjects: A Randomised Controlled Trial

Phase 1
Completed
Conditions
dyslipidemia (high level of low-density lipoprotein cholesterol (LDL-C) in the range of 130-160 mg/dL)
Clinical trial, Dyslipidemia, Lactobacillus paracasei, Probiotic, Vegetable and fruit juice
Registration Number
TCTR20220109001
Lead Sponsor
Bhumibol Adulyadej Hospital
Brief Summary

The results showed that the levels of TC, LDL-C, TG, and TG/ HDL-C ratio of the probiotic group (consumption of VFJ with L. paracasei) was significantly decreased compare to the placebo group (consumption of VFJ without L. paracasei). Whereas the HDL-C concentration in the probiotic group was higher than the placebo group. The consumption of VFJ with L. paracasei significantly decreased MDA level, increased CAT activity, and GPx activity in plasma, including increased BA level in feces of participants.

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
20
Inclusion Criteria

1.The subjects were required to be aged at least 18 years., 2. The subjects had a high level of low- density lipoprotein cholesterol (LDL-C) in the range of 130-160 mg/dL according to the National Cholesterol Education Program (NCEP)., 3. The subjects never received medical treatment for dyslipidemia.

Exclusion Criteria

1.Having family history of dyslipidemia, 2.Having gastrointestinal surgery, 3. Suffering from metabolic disorders, cardiovascular disease, thyroid disorder, kidney disease, and liver disease, 4. Having been treated with prebiotic and/or probiotic and/or nutrition supplements, 5. Taking other drugs which possibility affect the lipid metabolism, 6.Smoking and drinking alcohol during the clinical trial.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
lipid profile and bile acid at 30 days after end of the intervention TC (mg/dL) LDL-C (mg/dL) HDL-C (mg/dL) TG (mg/dL) and BA (micromole/L)
Secondary Outcome Measures
NameTimeMethod
Oxidative stress enzymes at 30 days after end of the intervention CAT (unit/mL) GPx (unit/mL) SOD (unit/mL)
© Copyright 2025. All Rights Reserved by MedPath